Robust real-world data on the effectiveness of biologic therapies in children with severe asthma remain limited, particularly ...

Key highlights include a strong emphasis on dupilumab, particularly in steroid-dependent asthma and in patients showing inadequate response to initial biologic therapy. The recommendations stress the ...

AstraZeneca (LSE:AZN) received US FDA approval for CALQUENCE as an all oral, fixed duration therapy for chronic lymphocytic ...

Chronic respiratory diseases such as asthma account for 4% of all deaths in South Africa and poverty is the main underlying driver of these diseases, say experts.

A new study published in The Journal of Allergy and Clinical Immunology showed that macrolide treatment probably improves ...

The predictive variables assessed were age at EGPA diagnosis, baseline eosinophil count, history of chronic sinusitis prior to diagnosis, and glucocorticoid-treated asthma at diagnosis.

Experts parse evidence for an early start ...

Chronic obstructive pulmonary disease (COPD) has become one of the world’s most lethal but least prioritised health crises. Each year, more than 3.5 million people die from COPD, a group of lung ...

New research from National Jewish Health suggests that long-acting beta-agonists (LABAs), commonly used in combination asthma inhalers, are not ...

Guidelines summarize how persons with a certain disease should be treated according to current knowledge, thereby supporting ...

Epinephrine improves ROSC in cardiac arrest but does not increase favorable neurologic recovery, raising ethical and ...

Panel featured legitimate experts in food allergy research and treatment ...